1. Milner, J Justin, Toma, Clara, Yu, Bingfei, Pipkin, Matthew E, Goldrath, Ananda W. 2017. Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours. In Nature, 552, 253-257. doi:10.1038/nature24993. https://pubmed.ncbi.nlm.nih.gov/29211713/
2. Wang, Yi, Qin, Xiuguang, Wu, Jieqing, Li, Hanchen, Zhao, Baosheng. 2014. Association of promoter methylation of RUNX3 gene with the development of esophageal cancer: a meta analysis. In PloS one, 9, e107598. doi:10.1371/journal.pone.0107598. https://pubmed.ncbi.nlm.nih.gov/25229459/
3. Vogiatzi, Paraskevi, De Falco, Giulia, Claudio, Pier Paolo, Giordano, Antonio. 2006. How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions. In Cancer biology & therapy, 5, 371-4. doi:. https://pubmed.ncbi.nlm.nih.gov/16627973/
4. Dubois, Patrick C A, Trynka, Gosia, Franke, Lude, Wijmenga, Cisca, van Heel, David A. 2010. Multiple common variants for celiac disease influencing immune gene expression. In Nature genetics, 42, 295-302. doi:10.1038/ng.543. https://pubmed.ncbi.nlm.nih.gov/20190752/
5. Guo, Changcun, Ding, Jie, Yao, Liping, Sun, Lijun, Fan, Daiming. . Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. In International journal of cancer, 116, 155-60. doi:. https://pubmed.ncbi.nlm.nih.gov/15756676/